AGs Cut $102M Deal With Indivior In Suboxone Antitrust Case

More than three dozen state-level enforcers reached a $102.5 million deal on Friday with Indivior Inc. to resolve claims that the drugmaker monopolized the market for the opioid addiction treatment Suboxone ahead of a looming September trial.

Related Keywords

Matthew Perlman ,Indivior Inc ,